Biogen (BIIB) Price Target Lifted to $422 at UBS Despite Caution on Tecfidera Estimates

Go back to Biogen (BIIB) Price Target Lifted to $422 at UBS Despite Caution on Tecfidera Estimates
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 211.62 -0.88 (0.41%)
Previous Close $212.50    52 Week High $333.65 
Open $210.42    52 Week Low $223.02 
Day High $212.14    P/E 27.10 
Day Low $209.00    EPS $7.81 
Volume 50,860